These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23019258)

  • 1. Correlation of cognitive impairment and thalamic atrophy in MS: for men only?
    Fisher E; Benedict RH
    Neurology; 2012 Oct; 79(17):1748-9. PubMed ID: 23019258
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
    Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcortical atrophy and cognition: sex effects in multiple sclerosis.
    Schoonheim MM; Popescu V; Rueda Lopes FC; Wiebenga OT; Vrenken H; Douw L; Polman CH; Geurts JJ; Barkhof F
    Neurology; 2012 Oct; 79(17):1754-61. PubMed ID: 23019265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
    Benedict RH; Hulst HE; Bergsland N; Schoonheim MM; Dwyer MG; Weinstock-Guttman B; Geurts JJ; Zivadinov R
    Mult Scler; 2013 Oct; 19(11):1478-84. PubMed ID: 23459570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognition in multiple sclerosis.
    Langdon DW
    Curr Opin Neurol; 2011 Jun; 24(3):244-9. PubMed ID: 21519256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
    Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
    J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
    Benedict RH; Bruce JM; Dwyer MG; Abdelrahman N; Hussein S; Weinstock-Guttman B; Garg N; Munschauer F; Zivadinov R
    Arch Neurol; 2006 Sep; 63(9):1301-6. PubMed ID: 16966509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
    Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
    Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI markers of destructive pathology in multiple sclerosis-related cognitive dysfunction.
    Rovaris M; Comi G; Filippi M
    J Neurol Sci; 2006 Jun; 245(1-2):111-6. PubMed ID: 16626748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI and cognition in multiple sclerosis.
    Filippi M; Rocca MA
    Neurol Sci; 2010 Nov; 31(Suppl 2):S231-4. PubMed ID: 20635114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M
    Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
    Mesaros S; Rocca MA; Absinta M; Ghezzi A; Milani N; Moiola L; Veggiotti P; Comi G; Filippi M
    Neurology; 2008 Mar; 70(13 Pt 2):1107-12. PubMed ID: 18272867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis.
    Bagnato F; Salman Z; Kane R; Auh S; Cantor FK; Ehrmantraut M; Gallo A; Ikonomidou VN; Ohayon J; Pellicano C; Stern SK; McFarland HF
    Mult Scler; 2010 Oct; 16(10):1203-12. PubMed ID: 20699284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
    Benedict RH; Weinstock-Guttman B; Fishman I; Sharma J; Tjoa CW; Bakshi R
    Arch Neurol; 2004 Feb; 61(2):226-30. PubMed ID: 14967771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
    Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis.
    Sumowski JF; Chiaravalloti N; Wylie G; Deluca J
    J Int Neuropsychol Soc; 2009 Jul; 15(4):606-12. PubMed ID: 19573279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical atrophy and personality in multiple sclerosis.
    Benedict RH; Hussein S; Englert J; Dwyer MG; Abdelrahman N; Cox JL; Munschauer FE; Weinstock-Guttman B; Zivadinov R
    Neuropsychology; 2008 Jul; 22(4):432-41. PubMed ID: 18590355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Default mode network disruption secondary to a lesion in the anterior thalamus.
    Jones DT; Mateen FJ; Lucchinetti CF; Jack CR; Welker KM
    Arch Neurol; 2011 Feb; 68(2):242-7. PubMed ID: 20937938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.